United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Johnson & Johnson announces $13.1bn acquisition of Shockwave Medical to strengthen medtech division In a monumental move within the medical technology sector, Johnson & Johnson (NYSE: JNJ) has announced its acquisition… byPallavi MadhirajuApril 8, 2024